Is Drugs Made In America Acquisition Corp. Ordinary Shares overvalued?

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) — key valuation metrics and fundamentals.

No verdict

Price

$10.71

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$260.0M

Dividend yield

0.0%

Return on equity

2.9%

Sector

Financial Services

Fair value compares DMAA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks